The Challenge: Involving Urologists in Cancer Care
Management of elevated PSAs, or the next testing equivalent, and prostate cancer should default to the urology world, just like always.
Prostate Cancer Coverage Extends Beyond Clinical Studies
It seems like the feature stories and meetings coverage this month singularly revolve around prostate cancer.
Thomas Neville's Dynamic Analysis of Multiple PSA Results Leads to Better Reliability, Insights
A new phase begins for Thomas Neville, PhD, a Yale and Stanford-trained engineer and economist who worked in energy before a prostate cancer diagnosis drew him into medical research.
Advanced Bladder Cancer Increases Suicide Risk, Study Says
Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report.
Task Force PSA Recommendation Needs Updating, LUGPA President Says
A United States Preventive Services Task Force recommendation against the use of prostate specific antigen testing needs to be updated, said Gary Kirsh, MD, president of the Large Urology Group Practice Association.
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.